Come up with a name for your new list and we'll add to it:
Fibrotech Therapeutics raised a round of funding on , . Investors include
Brandon Capital Partners.
Fibrotech is an Australian biopharmaceutical company developing a new class of drugs to prevent a massive health burden associated with fibrosis (tissue scarring). The Company develops novel anti-fibr…